Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Chew

Showing results (171-180 of 214) with videos related to

Pageof 22
Sort By:
Plos One|March 15, 2011
A clinical diagnostic model for predicting influenza among young adult military personnel with febrile respiratory illness in SingaporeVernon J Lee, Jonathan Yap, Alex R Cook, et al.
Frontiers in Immunology|September 21, 2023
Cyclone: an accessible pipeline to analyze, evaluate, and optimize multiparametric cytometry dataRavi K Patel, Rebecca G Jaszczak, Kwok Im, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Journal of Viral Hepatitis|September 16, 2020
Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in MyanmarYin Min Thaung, Charles S Chasela, Kara W Chew, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical TrialKara W Chew, Carlee Moser, Eric S Daar, et al.
Journal of the American Heart Association|December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
The Journal of Infectious Diseases|May 8, 2024
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2Manish C Choudhary, Rinki Deo, Teresa H Evering, et al.
Clinical and Translational Science|January 5, 2023
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trialsOriol Mitjà, Gilmar Reis, David R Boulware, et al.
Nature Immunology|May 19, 2026
Differential assembly of mouse and human tumor microenvironmentsTristan Courau, Rebecca G Jaszczak, Bushra Samad, et al.
Microbiology Spectrum|May 18, 2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolutionGregory E Edelstein, Tatum N Sass, Rinki Deo, et al.
Pageof 22

Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
Plos One|March 15, 2011
A clinical diagnostic model for predicting influenza among young adult military personnel with febrile respiratory illness in SingaporeVernon J Lee, Jonathan Yap, Alex R Cook, et al.
Frontiers in Immunology|September 21, 2023
Cyclone: an accessible pipeline to analyze, evaluate, and optimize multiparametric cytometry dataRavi K Patel, Rebecca G Jaszczak, Kwok Im, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Journal of Viral Hepatitis|September 16, 2020
Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in MyanmarYin Min Thaung, Charles S Chasela, Kara W Chew, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical TrialKara W Chew, Carlee Moser, Eric S Daar, et al.
Journal of the American Heart Association|December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
The Journal of Infectious Diseases|May 8, 2024
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2Manish C Choudhary, Rinki Deo, Teresa H Evering, et al.
Clinical and Translational Science|January 5, 2023
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trialsOriol Mitjà, Gilmar Reis, David R Boulware, et al.
Nature Immunology|May 19, 2026
Differential assembly of mouse and human tumor microenvironmentsTristan Courau, Rebecca G Jaszczak, Bushra Samad, et al.
Microbiology Spectrum|May 18, 2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolutionGregory E Edelstein, Tatum N Sass, Rinki Deo, et al.
Pageof 22